Illuminating the druggable genome: Pathways to progress

Drug Discov Today. 2023 Oct 25:103805. doi: 10.1016/j.drudis.2023.103805. Online ahead of print.ABSTRACTThere are ∼4500 genes within the 'druggable genome', the subset of the human genome that expresses proteins able to bind drug-like molecules, yet existing drugs only target a few hundred. A substantial subset of druggable proteins are largely uncharacterized or understudied, with many falling within G protein-coupled receptor (GPCR), ion channel, and kinase protein families. To improve scientific understanding of these three understudied protein families, the US National Institutes of Health launched the Illuminating the Druggable Genome Program. Now, as the it draws to a close, this review will lay out resources developed by the program that are intended to equip the scientific community with the tools necessary to explore previously understudied biology with the potential to rapidly impact human health.PMID:37890715 | DOI:10.1016/j.drudis.2023.103805
Source: Drug Discovery Today - Category: Drugs & Pharmacology Authors: Source Type: research